Memorial Sloan Kettering’s Precision Interception and Prevention (PIP) program combines the principles of precision medicine with research on prevention and early detection. The goal of this approach is to either prevent cancer from occurring or stop it at the earliest stages, when it’s easier to treat.
PIP is a focused, multidisciplinary research program dedicated to improving methods for screening, early detection, and risk assessment. The program aims to increase the early detection of cancer in people at a high risk, thereby saving lives and improving outcomes. PIP is not a broad screening program; rather, it concentrates on people who have the highest risk for developing cancer and creating ways to help them.
To accomplish this goal, PIP provides leadership, vision, and resources to multidisciplinary teams that focus on creating and enhancing programs for early detection and prevention.